Hypertension, Medication Adherence
Conditions
Brief summary
This study was a single-blinded, two-armed, randomized controlled trial comparing a medication self-management intervention to usual care for hypertensive elderly in the residential care facility. To explore the effect of stage-matched tailored education on disease management for hypertensive elderly. Patient were randomly assigned to either a 6-month trans-theoretical model-based medication management intervention group or a treatment-as-usual group. we would like to improve its adherence to the medicine prescribed by their own physician through five sessions of face-to-face interview which focused on anti-hypertensive medication-related information, the importance of medication refills, motivation, self-management and self-check skills.
Detailed description
This study was a single-blinded, two-armed, randomized controlled trial comparing a medication self-management intervention to usual care for hypertensive elderly in the residential care facility. From October 2018 to November 2018, convenience sampling was used to recruit 120 participants from one of the most extensive facilities in Zhengzhou, China. Individuals aged 65 years of age or older diagnosed had stage I or stage II hypertension (140-159/90-99 mm Hg or 160-180/100-110 mm Hg, respectively), as confirmed by the professional physician and prescribed anti-hypertensive medication by the physician for at least six months and with an estimated life expectancy of no less than six months were included.The intervention included five educational sessions focused on anti-hypertensive medication-related information, the importance of medication refills, motivation, self-management and self-check skills.
Interventions
BEHAVIORALbehavior management for anti-hypertensive medication
five sessions of educational interview and home visiting to improve medication-related self-management skills
OTHERplacebo group
treatment as usual
Sponsors
Jing Chang
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
65 Years to 95 Years
Healthy volunteers
No
Inclusion criteria
1. aged 65 years of age or older 2. diagnosed with a stage I or stage II hypertension (140-159/90-99 mm Hg or 160-180/100-110 mm Hg, respectively), as confirmed by the professional physician 3. prescribed anti-hypertensive medication by the physician for at least six months
Exclusion criteria
1. unable to communicate and take medications by themselves. 2. with an estimated life expectancy of no more than six months. -
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood Pressure | 0.3month.6month.3years | Sphygmomanometers，assessing Change from Baseline Blood Pressure at 3 years |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| medication adherence | 0.3month.6month.3years | Adherence to Refills and Medications Scale，The raw scores are changed from original metric to a 10-40 metric, in which lower scores means higher level of adherence |
| medication self-efficiency | 0.3month.6month.3years | Self-efficiency for appropriate medication use scale (SEAMS),It has 13 items and patients are asked about their level of confidence about taking medication correctly under a varied circumstance. Each item is evaluated by three-point Likert respond scale (1=not confident, 2=somewhat confident, 3=very confident), higher score means higher confidence |
| patient activation | 0.3month.6month.3years | patient activation measure-10 (PAM-10) scale.The raw scores are changed from original metric to a 0-100 metric, in which higher scores means higher level of activation |
Countries
China
Outcome results
None listed